Auckland, New Zealand, 13 June 2019 - Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that its 2019 Annual Shareholders’ Meeting will be held at the Paykel Building, Fisher & Paykel Healthcare, 15 Maurice Paykel Place, East Tamaki, Auckland, New Zealand on Wednesday, 28 August 2019 at 2pm (NZST).
In respect of its 2019 Annual Shareholders’ Meeting, Fisher & Paykel Healthcare Corporation Limited advises that the closing date for director nominations is 1 July 2019.
Nominations should be addressed to:
The Company Secretary
Fisher & Paykel Healthcare Corporation Limited
PO Box 14348 Panmure, Auckland 1741
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investors Contacts:
+64 (0) 27 578 9663
Investor Relations Manager
+64 (0) 27 807 8073
Notification of closing date for director nominations
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment